Recruiting
Phase 2

Tebentafusp & Radioembolization

Sponsor:

University of Miami

Code:

NCT06627244

Conditions

Metastatic Uveal Melanoma

Metastatic Uveal Melanoma in the Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tebentafusp

TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-26. This information was provided to ClinicalTrials.gov by University of Miami on 2025-03-25.